Managing expectational language: Translational genetic professionals consider the clinical potential of next-generation sequencing technologies

New Genetics and Society

Volumn 33, Issue 2, 2014, Pages 126-148

  Koay, Pei P ^a   Sharp, Richard R ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Clinical genomics; Expectations; New medical technologies

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CONCEPTUAL FRAMEWORK; EXPECTATION; EXPECTATIONAL LANGUAGE; GENE SEQUENCE; GENETIC SCREENING; GENOME; GENOMICS; HUMAN; INFORMATION PROCESSING; LANGUAGE; MEDICAL TECHNOLOGY; NEXT GENERATION SEQUENCING; PATIENT CARE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE;

EID: 84901022305     PISSN: 14636778     EISSN: 14699915     Source Type: Journal    
DOI: 10.1080/14636778.2014.910448     Document Type: Article

References (80)

1. Akrich, M. 1992. "The De-scription of Technical Objects." In Shaping Technology/Building Society: Studies in Sociotechnical Change, edited byW. E. Bijker and J. Law, 205-224. Cambridge, MA: MIT Press
2. Akrich, M., J. Nunes, F. Paterson, & V. Rabeharisoa. 2008. The Dynamics of Patient Organizations in Europe. Paris: Presses des Mines
3. Ashley, E. A., A. J. Butte, M. T. Wheeler, R. Chen, T. E. Klein, F. E. Dewey, J. T. Dudley, et al. 2010. "Clinical Assessment Incorporating a Personal Genome." The Lancet 375 (9725): 1525-1535
4. Barr, M., and D. Rose. 2008. "The Great Ambivalence: Factors Likely to Affect Service User and Public Acceptability of the Pharmacogenomics of Antidepressant Medication." Sociology of Health & Illness 30 (6): 944-958
5. Bates, B. R., J. A. Lynch, J. L. Bevan, and C. M. Condit. 2005. "Warranted ConcernsWarranted Outlooks: A Focus Group Study of Public Understandings of Genetic Research." Social Science & Medicine 60 (2): 331-344. (Pubitemid 39452549
6. Baudhuin, L. M., L. J. Donato, and T. S. Uphoff. 2012. "How Novel Molecular Diagnostic Technologies and Biomarkers are Revolutionizing Genetic Testing and Patient Care." Expert Review of Molecular Diagnostics 12 (1): 25-37
7. Bloss, C. S., N. J. Schork, and E. J. Topol. 2011. "Effect of Direct-To-Consumer Genome Wide Profiling to Assess Disease Risk." New England Journal of Medicine 364 (6): 524-534
8. Borup, M., N. Brown, K. Konrad, and H. Van Lente. 2006. "The Sociology of Expectations in Science and Technology." Technology Analysis & Strategic Management 18 (3-4): 285-298. (Pubitemid 44083929
9. ten Bosch, J. R., and W. W. Grody. 2008. "Keeping up with the Next Generation: Massively Parallel Sequencing in Clinical Diagnostics." The Journal of Molecular Diagnostics 10 (6): 484-492
10. Brown, N. 2003. "Hope against Hype - Accountability in Biopasts Presents and Future." Science Studies 16 (2): 3-21
11. Brown, N., and M. Michael. 2003. "A Sociology of Expectations: Retrospecting Prospects and Prospecting Retrospects." Technology Analysis and Strategic Management 15 (1): 3-18. (Pubitemid 36533586
12. Brown, N., B. Rappert, and A. Webster. 2000. "Introducing Contested Futures: From Looking into the Future to Looking at the Future." In Contested Futures: A Sociology of Prospective Technoscience, edited by N. Brown, B. Rappert, and A. Webster, 3-20. Aldershot: Ashgate
13. Choi, M., U. I. Scholl,W. Ji, T. Liu, I. R. Tikhonova, P. Zumbo, A. Nayir, et al. 2009. "Genetic Diagnosis by Whole Exome Capture and Massively Parallel DNA Sequencing." Proceedings of the National Academy of Sciences 106 (45): 19096-19101
14. Collins, H. M., and R. Evans. 2002. "The Third Wave of Science Studies: Studies of Expertise and Experience." Social Studies of Science 32 (2): 235-296. (Pubitemid 36737435
15. Condit, C. M. 1999. The Meanings of the Gene: Public Debates about Human Heredity. Madison: University of Wisconsin Press
16. Condit, C. M., and J. Lynch. 2012. "Recent Rhetorical Studies in Public Understanding of Science: Multiple Purposes and Strengths." Public Understanding of Science 21 (4): 386-400
17. Drmanac, R. M. 2012. "The Ultimate Genetic Test." Science 336 (6085): 1110-1112
18. Evans, J. P., E. M. Meslin, T. M. Marteau, and T. Caulfield. 2011. "Deflating the Genomic Bubble." Science 331 (6019): 861-862
19. Fortun, M. 2001. "Mediated Speculations in the Genomics Futures Market." New Genetics and Society 20 (2): 139-156. (Pubitemid 32783428
20. Fortun, M. 2008. Promising Genomics: Iceland and deCODE Genetics in a World of Speculation. Berkeley: University of California Press
21. Friend, S. H., and T. Ideker. 2011. "POINT: Are We Prepared for the Future Doctor Visit?" Nature Biotechnology 29 (3): 215-218
22. Harvey, A. 2009. "From Genetic Risk to Post-genomic Uncertainties: Nutrigenomics and the Birth of the Genetic Entrepreneur." New Genetics and Society 28 (2): 119-137
23. Hedgecoe, A. 2004. The Politics of Personalized Medicine: Pharmacogenetics in the Clinic. New York: Cambridge University Press
24. Hedgecoe, A. 2006. "Pharmacogenetics as Alien Science: Alzheimer's Disease Core Sets and Expectations." Social Studies of Science 36 (5): 723-752. (Pubitemid 44342847
25. Hedgecoe, A., and P. Martin. 2003. "The Drugs Don't Work: Expectations and the Shaping of Pharmacogenetics." Social Studies of Science 33 (3): 327-364. (Pubitemid 37340838
26. Hock, K. T., K. D. Christensen, B. M. Yashar, J. S. Roberts, S. E. Gollust, and W. R. Uhlmann. 2011. "Direct-To-Consumer Genetic Testing: An Assessment of Genetic Counselors' Knowledge and Beliefs." Genetics in Medicine 13 (4): 325-332
27. Hö rig, H., E. Marincola, and F. M. Marincola. 2005. "Obstacles and Opportunities in Translational Research." Nature Medicine 11 (7): 705-708
28. Horst, M. 2007. "Public Expectations of Gene Therapy: Scientific Futures and Their PerformativeEffects on Scientific Citizenship." Science Technology & Human Values 32 (2): 150-171
29. Kingsmore, S. F., and C. J. Saunders. 2011. "Deep Sequencing of Patient Genomes for Disease Diagnosis: When Will It Be Routine?" Science Translational Medicine 3 (87): 87ps23
30. Kitzinger, J. 1994. "The Methodology of Focus Groups: The Importance of Interaction Between Research Participants." Sociology of Health & Illness 16 (1): 103-121
31. Kitzinger, J., and C. Williams. 2005. "Forecasting Science Futures: Legitimising Hope and Calming Fears in the Embryo Stem Cell Debate." Social Science & Medicine 61: 731-740. (Pubitemid 40724616
32. Klee, E. W., N. L. Hoppman-Chaney, and M. J. Ferber. 2011. "Expanding DNA Diagnostic Panel Testing: Is More Better?" Expert Review of Molecular Diagnostics 11 (7): 703-711
33. Koboldt, D. C., K. M. Steinberg, D. E. Larson, R. K.Wilson, and E. R. Mardis. 2013. "The Next-Generation Sequencing Revolution and its Impact on Genomics." Cell 155 (1): 27-38
34. Kreiner, T., and K. T. Buck. 2005. "Moving Toward Whole-Genome Analysis: A Technology Perspective." American Journal of Health-System Pharmacy 62 (3): 296-305. (Pubitemid 40403546
35. Ku, C. S., D. N. Cooper, C. Polychronakos, N. Naidoo, M.Wu, and R. Soong. 2012. "Exome Sequencing: Dual Role as a Discovery and Diagnostic Tool." Annals of Neurology 71 (1): 5-14
36. Lupski, J. R., J. G. Reid, C. Gonzaga-Jauregui, D. R. Deiros, D. C. Y. Chen, L. Nazareth, M. Bainbridge et al. 2010. "Whole-Genome Sequencing in a Patient with Charcot-Marie-Tooth Neuropathy." New England Journal of Medicine 362 (13): 1181-1191
37. Mankoff, S. P., C. Brander, S. Ferrone, and F. M. Marincola. 2004. "Lost in Translation: Obstacles to Translational Medicine." Journal of Translational Medicine 2 (1): 14-18
38. Martin, P., N. Brown, and A. Kraft. 2008. "From Bedside to Bench? Communities of Promise Translational Research and the Making of Blood Stem Cells." Science as Culture 17 (1): 29-41
39. Martin, P., N. Brown, and A. Turner. 2008. "Capitalizing Hope: The Commercial Development of Umbilical Cord Blood Stem Cell Banking." New Genetics and Society 27 (2): 127-143. (Pubitemid 351882346
40. McBride, C. M., C. Wade, and K. A. Kaphingst. 2010. "Consumers' Views of Direct-To-Consumer Genetic Information." Annual Review of Genomics & Human Genetics 11: 427-446
41. McGowan, M., J. Fishman, and M. Lambrix. 2010. "Personal Genomics and Individual Identities: Motivations and Moral Imperatives of Early Users." New Genetics and Society 29 (3): 261-290
42. McGuire, A. L., C. M. Diaz, T. Wang, and S. G. Hilsenbeck. 2009. "Social Networkers' Attitudes Toward Direct-To-Consumer Personal Genome Testing." American Journal of Bioethics 9 (6- 7): 3-10
43. Meyerson, M., S. Gabriel, and G. Getz. 2010. "Advances in Understanding Cancer Genomes Through Second-Generation Sequencing." Nature Reviews Genetics 11 (10): 685-696
44. Michael, M., S.Wainwright, C.Williams, B. Farsides, and A. Cribb. 2007. "From Core Set to Assemblage: On the Dynamics of Exclusion and Inclusion in the Failure to Derive Beta Cells from Embryonic Stem Cells." Science Studies 20 (1): 5-25
45. Moreira, T., and P. Palladino. 2005. "Between Truth and Hope: On Parkinson's Disease Neurotransplantation and the Production of the Self." History of the Human Sciences 18 (3): 55-82. (Pubitemid 43497509
46. Nelkin, D. 1995. Selling Science: How the Press Covers Science. New York: W.H. Freeman
47. Nelkin, D., and S. Lindee. 1995. The DNA Mystique: The Gene as a Cultural Icon. New York: W.H. Freeman
48. Nerlich, B., and C. Halliday. 2007. "Avian Flu: The Creation of Expectations in the Interplay Between Science and the Media." Sociology of Health & Illness 29 (1): 46-65
49. Novas, C. 2006. "The Political Economy of Hope: Patients' Organizations Science and Biovalue." BioSocieties 1 (3): 289-305
50. O'Daniel, J. M., S. B. Haga, and H. F. Willard. 2010. "Considerations for the Impact of Personal Genome Information: A Study of Genomic Profiling among Genetics and Genomic Professionals." Journal of Genetic Counseling 19 (4): 387-401
51. O'Rourke, P. P. 2013. "Genomic Medicine: Too Great Expectations?" Clinical Pharmacology & Therapeutics 94 (2): 188-190
52. Oudshoorn, N., and T. J. Pinch, eds. 2003. How Users Matter: The Co-construction of Users and Technologies. Cambridge, MA: MIT Press
53. Petersen, A. 2001. "Biofantasies: Genetics and Medicine in the Print News Media." Social Science & Medicine 52 (8): 1255-1268. (Pubitemid 32101450
54. Petersen, A., and K. Seear. Dec 2011. "Technologies of Hope: Techniques of the Online Advertising of Stem Cell Treatments." New Genetics and Society 30 (4): 329-346
55. Pettersson, E., J. Lundeberg, and A. Ahmadian. 2008. "Generations of Sequencing Technologies." Genomics 93 (2): 105-111
56. Powell, K. P.,W. A. Cogswell, C. A. Christianson, G. Dave, A. Verma, S. Eubanks, and V. C. Henrich. 2011. "Primary Care Physicians' Awareness Experience and Opinions of Direct-To-Consumer Genetic Testing." Journal of Genetic Counseling 21 (1): 113-126
57. Raffan, E., and R. K. Semple. 2011. "Next Generation Sequencing - Implications for Clinical Practice." British Medical Bulletin 99 (1): 53-71
58. Rajan, K. S. 2006. Biocapital: TheConstitution ofPostgenomic Life.Durham, NC:Duke University Press
59. Rappert, B. 1999. "Rationalising the Future? Foresight in Science and Technology Policy Co-ordination." Futures 31 (6): 527-545. (Pubitemid 29351392
60. Rappert, B., and N. Brown. 2000. "Putting the Future in Its Place: Comparing Innovation Moments in Genetic Diagnostics and Telemedicine." New Genetics and Society 19 (1): 49-75. (Pubitemid 30224156
61. Roberts, N. J., J. T. Vogelstein, G. Parmigiani, K. W. Kinzler, B. Vogelstein, and V. E. Velculescu. 2012. "The Predictive Capacity of Personal Genome Sequencing." Science Translational Medicine 4 (133): 133-158
62. Rosengarten, M., and M. Michael. 2009. "The Performative Function of Expectations in Translating Treatment to Prevention: The Case of HIV Pre-exposure Prophylaxis PrEP." Social Science & Medicine 69 (7): 1049-1055
63. Ross, J. S., and M. Cronin. 2011. "Whole Cancer Genome Sequencing by Next-Generation Methods." American Journal of Clinical Pathology 136 (4): 527-539
64. Schadt, E. E., S. Turner, and A. Kasarskis. 2010. "A Window into Third-Generation Sequencing." Human Molecular Genetics 19 (Rev. Iss. 2): R227-R240
65. Selin, C. 2007. "Expectations and the Emergence of Nanotechnology." Science Technology & Human Values 32 (2): 196-220
66. Selin, C. 2008. "The Sociology of the Future: Tracing Stories of Technology and Time." Sociology Compass 2 (6): 1878-1895
67. Stewart, D.W., P. N. Shamdesani, and D.W. Rook. 2007. Focus Groups: Theory and Practice. Thousand Oaks, CA: Sage
68. Tucker, T., M. Marra, and J. M. Friedman. 2009. "Massively Parallel Sequencing: The Next Big Thing in Genetic Medicine." American Journal of Human Genetics 85 (2): 142-154
69. Turney, J. 1998. Frankenstein's Footsteps: Science Genetics and Popular Culture. New Haven, CT: Yale University Press
70. Tutton, R. 2007. "Constructing Participation in Genetic Databases: Citizen Governance and Ambivalence." Science Technology and Human Values 32 (2): 172-195
71. Tutton, R. 2011. "Promising Pessimism: Reading the Futures to Be Avoided in Biotech." Social Studies of Science 41 (3): 411-429
72. Tutton, R., A. Smart, P. A. Martin, R. Ashcroft, and G. T. H. Ellison. 2008. "Genotyping the Future: Scientists' Expectations about Race/Ethnicity after BiDil." Journal of Law Medicine & Ethics 36 (3): 464-470
73. Uhlmann, W. R., and R. S. Sharp. 2012. "Genetic Testing Integration Panels (GTIP): A Novel Approach for Considering Integration of Direct-To-Consumer and Other New Genetic Tests into Patient Care." Journal of Genetic Counseling 21 (3): 374-381
74. Van Dijck, Jose. 1997. Imagenation: Popular Images of Genetics. New York: NYU Press
75. Van Lente, H., and A. Rip. 1998. "The Rise of Membrane Technology: From Rhetorics to Social Reality." Social Studies of Science 28 (2): 221-254
76. Voelkerding, K. V., S. Dames, and J. D. Durtschi. 2010. "Voelkerding a Paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology." The Journal of Molecular Diagnostics 12 (5): 539-551
77. Wainwright, S. P., C. Williams, M. Michael, B. Farsides, and A. Cribb. 2006. "From Bench to Bedside? Biomedical Scientists' Expectations of Stem Cell Science as a Future Therapy for Diabetes." Social Studies of Medicine 63 (8): 2052-2064. (Pubitemid 44278345
78. Ware, S. M. 2011. "Genetic Diagnosis in Pediatric Cardiomyopathy: Clinical Application and Research Perspectives." Progress in Pediatric Cardiology 31 (2): 99-102
79. Webster, A., C. Douglas, and G. Lewis. 2009. "Making Sense of Medicines: Lay Pharmacology and Narratives of Safety and Efficacy." Science as Culture 18 (2): 233-247
80. Zhao, J., and S. F. A. Grant. 2011. "Advances in Whole Genome Sequencing Technology." Current Pharmaceutical Biotechnology 12 (2): 293-305